Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

115.69
BATS BZX Real-Time Price
As of 9:45am ET
 +0.57 / +0.50%
Today’s Change
43.86
Today|||52-Week Range
121.93
+58.24%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close115.12
Today’s open116.92
Day’s range116.63 - 117.70
Volume35,155
Average volume (3 months)1,130,500
Market cap$20.8B
Dividend yield--
Data as of 9:31am ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+31.22%
Earnings growth (next 5 years)+199.00%
Revenue growth (last year)+44.10%
P/E ratio1,526.3
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+2.06+1.65%
ZTSZoetis Inc+0.38+0.86%
MYLMylan NV-0.18-0.37%
ENDPEndo International P...-0.04-0.05%
Data as of 9:46am ET, 09/02/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers